Live tape
Top 8, mentions 7d10,771GOOGL2,061 mentions▲ +0.04SNDK1,523 mentions▲ +0.11SPCX1,494 mentions▲ +0.08NBIS1,420 mentions▲ +0.09HTZ1,232 mentions▲ +0.10NVDA1,187 mentions▲ +0.08META1,015 mentions▲ +0.03MSFT839 mentions▲ +0.06

Equity · Healthcare

CERS

Cerus Corporation · NasdaqGM

$3 +5.45% 1D Finazon · prior-day close · Aug 14, 2026
Price · Chart
Our own end-of-day closes 60 sessions
$3.5 $2.0 20 May 14 Aug

The line runs $2.70 on 20 May through $3 on 14 August, on a scale from $2.0 to $3.5. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of CERS over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 60 sessions over that window: $2.70 on 20 May 2026 through $3 on 14 August 2026.

Market cap $604.6M
52-week range $1.16 – $3.28
Avg volume 678.3K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 18, 2026

CERS insider trades

SEC Form 4

CERS has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 24 November 2025.

Date Insider Type Shares Value
24 Nov 2025 Jensen Chrystal Chief Legal Officer Sell 55,000 $94K
25 Aug 2025 Gregory Dean A. Buy 25,000 $31K

CERS reported financials

SEC EDGAR XBRL

CERS reported revenue of $233.8M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$15.6M.

Figure Reported Period
Revenue $233.8M 31 Dec 2025 fiscal year
Net income −$15.6M 31 Dec 2025 fiscal year
Diluted EPS −$0.08 31 Dec 2025 fiscal year
Total assets $205.2M 30 Jun 2026 at period end
Total equity $70.0M 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

CERS earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $-0.01 —
31 Mar 2026 Q1 2026 $-0.01 —
31 Dec 2025 FY 2025 $-0.08 —
30 Sep 2025 Q3 2025 $0.00 —
30 Jun 2025 Q2 2025 $-0.03 —
31 Mar 2025 Q1 2025 $-0.04 —
31 Dec 2024 FY 2024 $-0.11 —
30 Sep 2024 Q3 2024 $-0.02 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

CERS institutional holders

SEC Form 13F

9 of the 45 institutional funds we track reported a CERS position for the quarter ended 30 Jun 2026 — a combined $107.8M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
ARK Investment Management Held (±25%) −6.4% shares 17,932,099 $52.4M
Baker Bros. Advisors Trimmed −36.1% shares 6,395,431 $18.7M
D. E. Shaw & Co. Added +47.0% shares 5,485,983 $16.0M
Two Sigma Investments Added +26.9% shares 3,484,633 $10.2M
AQR Capital Management Held (±25%) −11.1% shares 1,878,275 $5.5M
Citadel Advisors New position 736,682 $2.2M
Renaissance Technologies Held (±25%) +16.0% shares 671,700 $2.0M
Point72 Asset Management New position 228,172 $666K
Millennium Management Trimmed −74.8% shares 108,481 $317K

Source: SEC EDGAR 13F filings

CERS fails-to-deliver

SEC CNS data

On 13 Jul 2026, 55,434 shares of CERS failed to deliver (about $173K).

Settlement date Shares failed Notional % of shares out
13 Jul 2026 55,434 $173K 0.028%
06 Jul 2026 11,937 $38K 0.006%

Source: SEC fails-to-deliver (CNS) data